Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Harvard Business School
Chinese Patent Office
McKinsey
Citi
Argus Health
Mallinckrodt
Healthtrust
Federal Trade Commission

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075795

« Back to Dashboard
NDA 075795 describes GLIPIZIDE, which is a drug marketed by Sandoz, Barr Labs Inc, Unique Pharm Labs, Sun Pharm Inds Inc, Watson Labs Teva, Mylan, Aurobindo Pharma Ltd, Accord Hlthcare, Par Pharm, Watson Labs, Vintage Pharms Llc, Ani Pharms Inc, Apotex, Mylan Pharms Inc, Zydus Pharms Usa Inc, Epic Pharma Llc, Heritage Pharms Inc, and Teva Pharms, and is included in twenty-four NDAs. It is available from fifty-four suppliers. Additional details are available on the GLIPIZIDE profile page.

The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.

Summary for NDA: 075795

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 075795

Ingredient-typeSulfonylurea Compounds

Suppliers and Packaging for NDA: 075795

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLIPIZIDE
glipizide
TABLET;ORAL 075795 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7968 0615-7968-05 15 TABLET in 1 BLISTER PACK (0615-7968-05)
GLIPIZIDE
glipizide
TABLET;ORAL 075795 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7968 0615-7968-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7968-30) > 5 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jun 13, 2001TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jun 13, 2001TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
McKinsey
Farmers Insurance
Chinese Patent Office
AstraZeneca
Covington
Fuji
Dow
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot